Macrophage Reprogramming with Anti‐miR223‐Loaded Artificial Protocells Enhances In Vivo Cancer Therapeutic Potential (Adv. Sci. 35/2022)
Source abstract
Abstract
Macrophage Reprogramming In article number 2202717, Stephen Mann, Paul Martin, and co‐workers used a zebrafish model of melanoma, which develops human‐like tumors mainly in the tail, to test a novel cancer immunotherapy approach based on the intravenous or direct injection of miniature artificial protocells that can circulate in blood and deliver reprogramming cargoes to immune cells to enhance their anti‐cancer potential. [Image: see text]
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References
Reference metadata was not supplied for this record.